Stacy Price, M.S.

Chief Technology and Manufacturing Officer at Invivyd

Since March 27, 2023

Age

55 years

Education

Holds an M.S. in Biochemical Engineering and a B.S. in Chemical Engineering from Tufts University.

Tenure

Started tenure at Invivyd, Inc. as Chief Technology and Manufacturing Officer on March 27, 2023, bringing over 25 years of experience in biotechnology operations management.

Also at Invivyd

JAJ

Jill Andersen, J.D.

Chief Legal Officer and Corporate Secretary

View →

JGM

Julie Green, M.B.A.

Chief Human Resources Officer (CHRO)

View →

RAP

Robert Allen, Ph.D.

Chief Scientific Officer (CSO)

View →

About

Stacy Price, M.S. is a seasoned executive with over 25 years of experience in biotechnology operations management, having held high‐level technical roles at companies such as Akouos, Inc. and Ziopharm Oncology, Inc..

She currently serves as the Chief Technology and Manufacturing Officer at Invivyd, Inc., joining on March 27, 2023, and has been instrumental in shaping technical and manufacturing strategies at the company.

Her career is marked by a commitment to operational excellence and innovation, underpinned by her strong educational background in biochemical and chemical engineering. This blend of technical expertise and extensive leadership experience enables her to address complex challenges in the biotechnology industry effectively.

Past Roles

Organization	Role	Date Range	Details
Akouos, Inc.	Chief Technical Officer	November 2021 to March 2023	Established technical operations strategy for multiple adeno-associated virus combination gene therapy programs; contributed to IND application
Ziopharm Oncology, Inc.	Senior Vice President of Technical Operations	February 2020 to September 2021	Oversaw CMC strategy and facilities construction for a research and manufacturing site for cell and combination gene therapy products
Ziopharm Oncology, Inc.	Vice President of Technical Operations	May 2017 to February 2020	Oversaw the development and delivery of CMC strategy and facilities construction for cell and combination gene therapy products
Various	Multiple manufacturing and operational roles	N/A	Held roles of increasing responsibility across the pharmaceutical and biotechnology industry

Fixed Compensation

Data from FY 2024

Component Name	Amount	Payment Schedule	Additional Details
Base Salary	N/A	N/A	No specific details provided for 2024
Equity Compensation	N/A	N/A	No specific details provided for 2024
Other Benefits	N/A	N/A	No specific details provided for 2024
Expense Reimbursement	N/A	N/A	No specific details provided for 2024

Performance Compensation

Data from FY 2024

No information available on performance compensation for 2024